FSD Pharma Inc.
NASDAQ: HUGE0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Zeeshan Saeed
- Employees
- 17
- Headquarters
- Toronto, Canada
- IPO year
- 2018
- Market cap
- $66.7K
- Website
- https://www.fsdpharma.com
Loading HUGE…
Loading profile data…Frequently asked questions about HUGE
What does FSD Pharma Inc. (HUGE) do?
FSD Pharma Inc. is a biopharmaceutical research and development company, operating through its various subsidiaries. The firm's leading drug candidate, FSD-201, is currently undergoing Phase II clinical trials for the treatment of COVID-19 disease. Additionally, FSD Pharma is actively developing Lucid-PSYCH, a psychoactive molecule identified fo...
Where does HUGE trade?
FSD Pharma Inc. (HUGE) trades on the NASDAQ Capital Market.
What sector is HUGE in?
FSD Pharma Inc. (HUGE) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of FSD Pharma Inc.?
Zeeshan Saeed is the chief executive officer of FSD Pharma Inc. (HUGE).
Where is FSD Pharma Inc. headquartered?
FSD Pharma Inc. is headquartered in Canada.
Does HUGE pay a dividend?
FSD Pharma Inc. (HUGE) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did HUGE go public?
FSD Pharma Inc. (HUGE) completed its initial public offering in 2018.